Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Lynx Therapeutics' LR-3280 licensed to Tanabe Seiyaku

July 19, 1996

FO-2047: Kitasato Institute's lipid peroxidation inhibitor

July 19, 1996

LDL oxidation inhibitors as arteriosclerosis/myocardial ischemia treatment from Chugai

July 19, 1996

Benzofuran smooth muscle proliferation inhibitors from Lilly

July 19, 1996

Imidapril available in Pakistan and Korea

July 19, 1996

PST-2238: a selective Na+/K+-ATPase inhibitor

July 19, 1996

Potential hypertension treatment from Pola

July 19, 1996

NEP inhibitors described by Tanabe Seiyaku

July 19, 1996

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

Bristol-Myers Squibb's Pravachol cleared by FDA for new indication

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...